Nathan Price, PhD

Dr. Nathan Price is Professor and Co-Director of the Center for Human Healthspan at the Buck Institute for Research on Aging. His academic career includes previous positions as Professor and Associate Director of the Institute for Systems Biology, and Assistant Professor at the University of Illinois, Urbana–Champaign. Dr. Price holds affiliate faculty status at the University of Washington in Bioengineering and Computer Science & Engineering. Dr. Price has authored more than 210 peer-reviewed publications and delivered 250+ talks and keynotes. Dr. Price’s expertise extends beyond academia into the business world. He is Chief Scientific Officer of Thorne, a science-driven wellness company serving ~5 million customers and 50,000 health-care practitioners. Previously, he was Co-CEO of Onegevity, an AI health intelligence company that merged with Thorne, and he was part of the presenting team that took Thorne HealthTech through its NASDAQ IPO in 2021. He also co-founded Arivale and served on its Board of Directors; raising over $53M, including a $36M Series B led by ARCH Venture Partners. His work has garnered numerous accolades. In 2019, he was named one of 10 Emerging Leaders in Health and Medicine by the National Academy of Medicine, and in 2021 he was appointed to the Board on Life Sciences of the National Academies of Sciences, Engineering, and Medicine (NASEM). Additional recognition includes an NSF CAREER award, being named a Camille Dreyfus Teacher-Scholar, and receiving the 2016 Grace A. Goldsmith Award for pioneering “scientific wellness.” He is also a fellow of the American Institute for Medical and Biological Engineering and previously served as Chair of the NIH Study Section on Modeling and Analysis of Biological Systems (MABS). He was the 2023 recipient of the Alexander & Mildred Seelig Award for Science from the American Nutrition Association.